Cancer Center members contribute to the mission of the Center via their participation in research, including laboratory, clinical, and population- based efforts. Membership alignment is limited to one program.
Primary Criteria for Membership
- Active cancer research as a primary professional focus
- Interest in the application of research to improve cancer care
Learn more about membership types and categories.
HCI Membership Benefits At-a-Glance
Eligibility for: | Type 1 | Type 2 | Type 3 |
HCI Investigator Designation | X | X | X |
CC Leadership |
X |
||
HCI Translational Scholar |
X |
||
Strategic Planning | X | X | |
Input on Program, Shared Resource Development | X | X | |
Program Funding | X* | X* | |
CIT Funding | X* | X* | |
Team Science Acceleration Funding | X | X* | |
Translational Science Initiative Funding | X | X* | |
CCSG Supplement Funding | X* | X* | |
ACS Seed Funding | X | ||
Cancer Biostatistics Support | X | X | X |
Shared Resources Access | X | X | X |
Clinical Research Support (cancer-focused interventional treatment trials) | X | X | X |
Receipt of, or Participation in: | |||
Funding Announcements | X | X | X |
HCI Newsletter | X | X | X |
Retreats/Symposia, etc. | X | X | X |
*Details regarding funding opportunities can be found on the Benefits and Responsibilities page.
Cancer Center Director
HCI Senior Directors
Neeraj Agarwal, MD
Clinical Research Innovation
Donald E. Ayer, PhD
Cancer Training and Career Enhancement
Rachel Ceballos, PhD
Community Outreach and Engagement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Kolawole S. Okuyemi, MD, MPH
Equity, Diversity, and Inclusion
Tracy Onega, PhD, MS
Population Sciences
Aik Choon Tan, PhD
Data Science
Alana Welm, PhD
Basic Science
Theresa Werner, MD
Clinical Research
David Wetter, PhD, MS
Cancer Health Equity Science
Program Leadership
Nuclear Control of Cell Growth and Differentiation
Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader
Cell Response and Regulation
Sheri Holmen, PhD
Leader
Experimental Therapeutics
Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader
Cancer Control and Population Sciences
Jennifer Doherty, MS, PhD
Co-Leader
Kathleen Mooney, PhD
Co-Leader